276
Participants
Start Date
March 31, 2000
Primary Completion Date
September 30, 2005
asparaginase
cyclophosphamide
cytarabine
daunorubicin hydrochloride
dexamethasone
doxorubicin hydrochloride
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sulfate
Herbert Irving Comprehensive Cancer Center, New York
Albert Einstein Clinical Cancer Center, The Bronx
State University of New York - Upstate Medical University, Syracuse
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Mayo Clinic Cancer Center, Rochester
Saint Jude Midwest Affiliate, Peoria
Baylor College of Medicine, Houston
Lucile Packard Children's Hospital at Stanford, Palo Alto
Children's Hospital and Regional Medical Center - Seattle, Seattle
Children's Hospital Los Angeles, Los Angeles
UCSF Comprehensive Cancer Center, San Francisco
Children's National Medical Center, Washington D.C.
Indiana University Cancer Center, Indianapolis
Dana-Farber Cancer Institute, Boston
University of Mississippi Medical Center, Jackson
Children's Hospital Medical Center - Cincinnati, Cincinnati
Doernbecher Children's Hospital, Portland
University of Texas Medical Branch, Galveston
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK